APO Research
Talk to an analyst

APO RESEARCH · REPORT

Whole Plasmid Sequencing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Whole Plasmid Sequencing Market Outlook and Growth Opportunities 2026

16 April 2026Not stated

Choose your research edition.

Industry ResearchWhole Plasmid Sequencing Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Whole Plasmid Sequencing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Whole Plasmid Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Whole Plasmid Sequencing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Whole Plasmid Sequencing Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Whole Plasmid Sequencing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Whole Plasmid Sequencing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Whole Plasmid Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Whole Plasmid Sequencing market include Eurofins Genomics, GenScript, Plasmidsaurus, Genewiz, Macrogen Europe, Source BioScience, Psomagen, BaseClear B.V. and Molecular Cloning Laboratories (MCLAB), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Whole Plasmid Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Whole Plasmid Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Whole Plasmid Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Whole Plasmid Sequencing market.

Whole Plasmid Sequencing Segment by Company

Eurofins Genomics

GenScript

Plasmidsaurus

Genewiz

Macrogen Europe

Source BioScience

Psomagen

BaseClear B.V.

Molecular Cloning Laboratories (MCLAB)

Polyplus

Elim Biopharm

SnapGene

Full Circle Labs

Unveil Bio

Microsynth AG

CD Genomics

Whole Plasmid Sequencing Segment by Type

Plasmid Regular (2.5 – 25 kb)

Plasmid Large (25 – 125 kb)

Plasmid XL (125 – 300 kb)

Others

Whole Plasmid Sequencing Segment by Application

Biopharmaceutical Companies

Research Institutions

Others

Whole Plasmid Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Whole Plasmid Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Whole Plasmid Sequencing key companies, revenue, market share, and recent developments.

3. To split the Whole Plasmid Sequencing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Whole Plasmid Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Whole Plasmid Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Whole Plasmid Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Plasmid Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Whole Plasmid Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Plasmid Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Plasmid Sequencing industry.

Chapter 3: Detailed analysis of Whole Plasmid Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Whole Plasmid Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Whole Plasmid Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Whole Plasmid Sequencing Industry Trends Table 2. Whole Plasmid Sequencing Industry Drivers Table 3. Whole Plasmid Sequencing Industry Opportunities and Challenges Table 4. Whole Plasmid Sequencing Industry Restraints Table 5. Global Whole Plasmid Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Whole Plasmid Sequencing Revenue Share by Company (2021-2026) Table 7. Global Whole Plasmid Sequencing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Whole Plasmid Sequencing Key Company Manufacturing Base & Headquarters Table 9. Global Whole Plasmid Sequencing Company, Product Type & Application Table 10. Global Whole Plasmid Sequencing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Whole Plasmid Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Plasmid Regular (2.5 – 25 kb) Table 15. Significant Companies of Plasmid Large (25 – 125 kb) Table 16. Significant Companies of Plasmid XL (125 – 300 kb) Table 17. Significant Companies of Others Table 18. Global Whole Plasmid Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Whole Plasmid Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Whole Plasmid Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Whole Plasmid Sequencing Sales Value Share by Type (2021-2026) Table 22. Global Whole Plasmid Sequencing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Biopharmaceutical Companies Table 24. Significant Companies of Research Institutions Table 25. Significant Companies of Others Table 26. Global Whole Plasmid Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Whole Plasmid Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Whole Plasmid Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Whole Plasmid Sequencing Sales Value Share by Application (2021-2026) Table 30. Global Whole Plasmid Sequencing Sales Value Share by Application (2027-2032) Table 31. Global Whole Plasmid Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Whole Plasmid Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Whole Plasmid Sequencing Sales Value Share by Region (2021-2026) Table 34. Global Whole Plasmid Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Whole Plasmid Sequencing Sales Value Share by Region (2027-2032) Table 36. Global Whole Plasmid Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Whole Plasmid Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Whole Plasmid Sequencing Sales Value Market Share by Country (2021-2026) Table 39. Global Whole Plasmid Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Whole Plasmid Sequencing Sales Value Market Share by Country (2027-2032) Table 41. Eurofins Genomics Company Information Table 42. Eurofins Genomics Business Overview Table 43. Eurofins Genomics Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Eurofins Genomics Whole Plasmid Sequencing Product Portfolio Table 45. Eurofins Genomics Recent Development Table 46. GenScript Company Information Table 47. GenScript Business Overview Table 48. GenScript Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. GenScript Whole Plasmid Sequencing Product Portfolio Table 50. GenScript Recent Development Table 51. Plasmidsaurus Company Information Table 52. Plasmidsaurus Business Overview Table 53. Plasmidsaurus Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Plasmidsaurus Whole Plasmid Sequencing Product Portfolio Table 55. Plasmidsaurus Recent Development Table 56. Genewiz Company Information Table 57. Genewiz Business Overview Table 58. Genewiz Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Genewiz Whole Plasmid Sequencing Product Portfolio Table 60. Genewiz Recent Development Table 61. Macrogen Europe Company Information Table 62. Macrogen Europe Business Overview Table 63. Macrogen Europe Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Macrogen Europe Whole Plasmid Sequencing Product Portfolio Table 65. Macrogen Europe Recent Development Table 66. Source BioScience Company Information Table 67. Source BioScience Business Overview Table 68. Source BioScience Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Source BioScience Whole Plasmid Sequencing Product Portfolio Table 70. Source BioScience Recent Development Table 71. Psomagen Company Information Table 72. Psomagen Business Overview Table 73. Psomagen Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Psomagen Whole Plasmid Sequencing Product Portfolio Table 75. Psomagen Recent Development Table 76. BaseClear B.V. Company Information Table 77. BaseClear B.V. Business Overview Table 78. BaseClear B.V. Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. BaseClear B.V. Whole Plasmid Sequencing Product Portfolio Table 80. BaseClear B.V. Recent Development Table 81. Molecular Cloning Laboratories (MCLAB) Company Information Table 82. Molecular Cloning Laboratories (MCLAB) Business Overview Table 83. Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Product Portfolio Table 85. Molecular Cloning Laboratories (MCLAB) Recent Development Table 86. Polyplus Company Information Table 87. Polyplus Business Overview Table 88. Polyplus Whole Plasmid Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Polyplus Whole Plasmid Sequencing Product Portfolio Table 90. Polyplus Recent Development Table 91. Elim Biopharm Company Information Table 92. Elim Biopharm Business Overview Table 93. Elim Biopharm Whole Plasmid Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Elim Biopharm Whole Plasmid Sequencing Product Portfolio Table 95. Elim Biopharm Recent Development Table 96. SnapGene Company Information Table 97. SnapGene Business Overview Table 98. SnapGene Whole Plasmid Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. SnapGene Whole Plasmid Sequencing Product Portfolio Table 100. SnapGene Recent Development Table 101. Full Circle Labs Company Information Table 102. Full Circle Labs Business Overview Table 103. Full Circle Labs Whole Plasmid Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Full Circle Labs Whole Plasmid Sequencing Product Portfolio Table 105. Full Circle Labs Recent Development Table 106. Unveil Bio Company Information Table 107. Unveil Bio Business Overview Table 108. Unveil Bio Whole Plasmid Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Unveil Bio Whole Plasmid Sequencing Product Portfolio Table 110. Unveil Bio Recent Development Table 111. Microsynth AG Company Information Table 112. Microsynth AG Business Overview Table 113. Microsynth AG Whole Plasmid Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Microsynth AG Whole Plasmid Sequencing Product Portfolio Table 115. Microsynth AG Recent Development Table 116. CD Genomics Company Information Table 117. CD Genomics Business Overview Table 118. CD Genomics Whole Plasmid Sequencing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. CD Genomics Whole Plasmid Sequencing Product Portfolio Table 120. CD Genomics Recent Development Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Whole Plasmid Sequencing Product Image Figure 2. Global Whole Plasmid Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Whole Plasmid Sequencing Market Size (2021-2032) & (US$ Million) Figure 4. Global Whole Plasmid Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Plasmid Regular (2.5 – 25 kb) Image Figure 8. Plasmid Large (25 – 125 kb) Image Figure 9. Plasmid XL (125 – 300 kb) Image Figure 10. Others Image Figure 11. Global Whole Plasmid Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Whole Plasmid Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Whole Plasmid Sequencing Sales Value Share by Type (2021-2032) Figure 14. Biopharmaceutical Companies Image Figure 15. Research Institutions Image Figure 16. Others Image Figure 17. Global Whole Plasmid Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Whole Plasmid Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Whole Plasmid Sequencing Sales Value Share by Application (2021-2032) Figure 20. Global Whole Plasmid Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Whole Plasmid Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Whole Plasmid Sequencing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Whole Plasmid Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Whole Plasmid Sequencing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Whole Plasmid Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Whole Plasmid Sequencing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Whole Plasmid Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Whole Plasmid Sequencing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Whole Plasmid Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Whole Plasmid Sequencing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Whole Plasmid Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmid Regular (2.5 – 25 kb)
  • Plasmid Large (25 – 125 kb)
  • Plasmid XL (125 – 300 kb)
  • Others
Applications
  • Biopharmaceutical Companies
  • Research Institutions
  • Others
Companies covered
  • Eurofins Genomics
  • GenScript
  • Plasmidsaurus
  • Genewiz
  • Macrogen Europe
  • Source BioScience
  • Psomagen
  • BaseClear B.V.
  • Molecular Cloning Laboratories (MCLAB)
  • Polyplus
  • Elim Biopharm
  • SnapGene
  • Full Circle Labs
  • Unveil Bio
  • Microsynth AG
  • CD Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Whole Plasmid Sequencing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Whole Plasmid Sequencing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Whole Plasmid Sequencing Market Dynamics
  1. 2.1 Whole Plasmid Sequencing Industry Trends
  2. 2.2 Whole Plasmid Sequencing Industry Drivers
  3. 2.3 Whole Plasmid Sequencing Industry Opportunities and Challenges
  4. 2.4 Whole Plasmid Sequencing Industry Restraints
3 Whole Plasmid Sequencing Market by Company
  1. 3.1 Global Whole Plasmid Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Whole Plasmid Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Whole Plasmid Sequencing Company Ranking (2024-2026)
  4. 3.4 Global Whole Plasmid Sequencing Company Manufacturing Base and Headquarters
  5. 3.5 Global Whole Plasmid Sequencing Company Product Type and Application
  6. 3.6 Global Whole Plasmid Sequencing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Whole Plasmid Sequencing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Whole Plasmid Sequencing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Whole Plasmid Sequencing Market by Type
  1. 4.1 Whole Plasmid Sequencing Type Introduction
  2. 4.1.1 Plasmid Regular (2.5 – 25 kb)
  3. 4.1.2 Plasmid Large (25 – 125 kb)
  4. 4.1.3 Plasmid XL (125 – 300 kb)
  5. 4.1.4 Others
  6. 4.2 Global Whole Plasmid Sequencing Sales Value by Type
  7. 4.2.1 Global Whole Plasmid Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Whole Plasmid Sequencing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Whole Plasmid Sequencing Sales Value Share by Type (2021-2032)
5 Whole Plasmid Sequencing Market by Application
  1. 5.1 Whole Plasmid Sequencing Application Introduction
  2. 5.1.1 Biopharmaceutical Companies
  3. 5.1.2 Research Institutions
  4. 5.1.3 Others
  5. 5.2 Global Whole Plasmid Sequencing Sales Value by Application
  6. 5.2.1 Global Whole Plasmid Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Whole Plasmid Sequencing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Whole Plasmid Sequencing Sales Value Share by Application (2021-2032)
6 Whole Plasmid Sequencing Regional Value Analysis
  1. 6.1 Global Whole Plasmid Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Whole Plasmid Sequencing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Whole Plasmid Sequencing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Whole Plasmid Sequencing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Whole Plasmid Sequencing Sales Value (2021-2032)
  7. 6.3.2 North America Whole Plasmid Sequencing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Whole Plasmid Sequencing Sales Value (2021-2032)
  10. 6.4.2 Europe Whole Plasmid Sequencing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Whole Plasmid Sequencing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Whole Plasmid Sequencing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Whole Plasmid Sequencing Sales Value (2021-2032)
  16. 6.6.2 South America Whole Plasmid Sequencing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Whole Plasmid Sequencing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Whole Plasmid Sequencing Sales Value Share by Country, 2025 VS 2032
7 Whole Plasmid Sequencing Country-level Value Analysis
  1. 7.1 Global Whole Plasmid Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Whole Plasmid Sequencing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Whole Plasmid Sequencing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Whole Plasmid Sequencing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Whole Plasmid Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Whole Plasmid Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Whole Plasmid Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Genomics
  2. 8.1.1 Eurofins Genomics Company Information
  3. 8.1.2 Eurofins Genomics Business Overview
  4. 8.1.3 Eurofins Genomics Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Genomics Whole Plasmid Sequencing Product Portfolio
  6. 8.1.5 Eurofins Genomics Recent Developments
  7. 8.2 GenScript
  8. 8.2.1 GenScript Company Information
  9. 8.2.2 GenScript Business Overview
  10. 8.2.3 GenScript Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GenScript Whole Plasmid Sequencing Product Portfolio
  12. 8.2.5 GenScript Recent Developments
  13. 8.3 Plasmidsaurus
  14. 8.3.1 Plasmidsaurus Company Information
  15. 8.3.2 Plasmidsaurus Business Overview
  16. 8.3.3 Plasmidsaurus Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Plasmidsaurus Whole Plasmid Sequencing Product Portfolio
  18. 8.3.5 Plasmidsaurus Recent Developments
  19. 8.4 Genewiz
  20. 8.4.1 Genewiz Company Information
  21. 8.4.2 Genewiz Business Overview
  22. 8.4.3 Genewiz Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Genewiz Whole Plasmid Sequencing Product Portfolio
  24. 8.4.5 Genewiz Recent Developments
  25. 8.5 Macrogen Europe
  26. 8.5.1 Macrogen Europe Company Information
  27. 8.5.2 Macrogen Europe Business Overview
  28. 8.5.3 Macrogen Europe Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Macrogen Europe Whole Plasmid Sequencing Product Portfolio
  30. 8.5.5 Macrogen Europe Recent Developments
  31. 8.6 Source BioScience
  32. 8.6.1 Source BioScience Company Information
  33. 8.6.2 Source BioScience Business Overview
  34. 8.6.3 Source BioScience Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Source BioScience Whole Plasmid Sequencing Product Portfolio
  36. 8.6.5 Source BioScience Recent Developments
  37. 8.7 Psomagen
  38. 8.7.1 Psomagen Company Information
  39. 8.7.2 Psomagen Business Overview
  40. 8.7.3 Psomagen Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Psomagen Whole Plasmid Sequencing Product Portfolio
  42. 8.7.5 Psomagen Recent Developments
  43. 8.8 BaseClear B.V.
  44. 8.8.1 BaseClear B.V. Company Information
  45. 8.8.2 BaseClear B.V. Business Overview
  46. 8.8.3 BaseClear B.V. Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BaseClear B.V. Whole Plasmid Sequencing Product Portfolio
  48. 8.8.5 BaseClear B.V. Recent Developments
  49. 8.9 Molecular Cloning Laboratories (MCLAB)
  50. 8.9.1 Molecular Cloning Laboratories (MCLAB) Company Information
  51. 8.9.2 Molecular Cloning Laboratories (MCLAB) Business Overview
  52. 8.9.3 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Molecular Cloning Laboratories (MCLAB) Whole Plasmid Sequencing Product Portfolio
  54. 8.9.5 Molecular Cloning Laboratories (MCLAB) Recent Developments
  55. 8.10 Polyplus
  56. 8.10.1 Polyplus Company Information
  57. 8.10.2 Polyplus Business Overview
  58. 8.10.3 Polyplus Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Polyplus Whole Plasmid Sequencing Product Portfolio
  60. 8.10.5 Polyplus Recent Developments
  61. 8.11 Elim Biopharm
  62. 8.11.1 Elim Biopharm Company Information
  63. 8.11.2 Elim Biopharm Business Overview
  64. 8.11.3 Elim Biopharm Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Elim Biopharm Whole Plasmid Sequencing Product Portfolio
  66. 8.11.5 Elim Biopharm Recent Developments
  67. 8.12 SnapGene
  68. 8.12.1 SnapGene Company Information
  69. 8.12.2 SnapGene Business Overview
  70. 8.12.3 SnapGene Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SnapGene Whole Plasmid Sequencing Product Portfolio
  72. 8.12.5 SnapGene Recent Developments
  73. 8.13 Full Circle Labs
  74. 8.13.1 Full Circle Labs Company Information
  75. 8.13.2 Full Circle Labs Business Overview
  76. 8.13.3 Full Circle Labs Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Full Circle Labs Whole Plasmid Sequencing Product Portfolio
  78. 8.13.5 Full Circle Labs Recent Developments
  79. 8.14 Unveil Bio
  80. 8.14.1 Unveil Bio Company Information
  81. 8.14.2 Unveil Bio Business Overview
  82. 8.14.3 Unveil Bio Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Unveil Bio Whole Plasmid Sequencing Product Portfolio
  84. 8.14.5 Unveil Bio Recent Developments
  85. 8.15 Microsynth AG
  86. 8.15.1 Microsynth AG Company Information
  87. 8.15.2 Microsynth AG Business Overview
  88. 8.15.3 Microsynth AG Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Microsynth AG Whole Plasmid Sequencing Product Portfolio
  90. 8.15.5 Microsynth AG Recent Developments
  91. 8.16 CD Genomics
  92. 8.16.1 CD Genomics Company Information
  93. 8.16.2 CD Genomics Business Overview
  94. 8.16.3 CD Genomics Whole Plasmid Sequencing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CD Genomics Whole Plasmid Sequencing Product Portfolio
  96. 8.16.5 CD Genomics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst